Introduction
Cases of granulomatous hepatitis are well characterized in terms of their infective and idiopathic etiology and association with drugs and HIV co-infection. [1] [2] [3] Etiologically, granulomas may be infective or non-infective. The infective causes include bacteria, fungi, mycobacteria, and viruses (Table I ). In the non-infective types, the causes may be sarcoidosis, drugs or idiopathic (Table II) . The drug causes include non-steroidal anti-inflammatory drugs, antibiotics, contrast medium, anti-convulsive agents, and drugs used for treatment of HCV infection. Thus, there is an extensive spectrum of etiologies.
Case report
A 40-year-old male Mexican was admitted to hospital for evaluation of hypertransaminasemia (alanine aminotransaminase 63 U/L; aspartate aminotransferase 40 U/L) and painful neck and shoulders. Chronic active hepatitis caused by the hepatitis C virus was diagnosed. Serum HCV RNA concentration was 1,000,000 copies/mL, and the viral genotype was 1b. Further examination was instituted because of the simultaneous finding of granulomas in a liver biopsy. The patient did not give a history of any use of intravenous drugs and we found no other co-infections by laboratory tests.
Discussion
The morphological aspects of HCV infection have been described during the past three decades. [4] [5] [6] [7] [8] These differing morphological and clinical diseases were first reported as non-A, non-B hepatitis. [9] [10] [11] In 1989, the viral agent, HCV, was identified and isolated, 12, 13 and almost all cases of non-A non-B hepatitis were related to this viral agent. Most histopathological changes have been described following percutaneous or transjugular biopsies.
The histopathological changes are reported according to the hepatic area affected: the portal and periportal areas and the hepatic parenchyma. The disease is described in terms of the duration of chronic hepatitis, with activity in different grades, 7, 14, 15 steatosis and fibrosis. The spectrum of histological changes is related to the degree of lymphocyte or lymphoplasmocyte infiltration into the liver, and to the necroinflammatory damage caused. The pathological and pharmacological investigations aim to evaluate the fibrosis and arrest it.
How can we explain the prevalence of granulomas in clinical hepatitis C? This is an item not well described for these patients, because publications have not identified granulomas in liver biopsies of patients with HCV, by Tru-cut needle, trans-jugular or open biopsies. However, other investigators have reported granulomas in patients with HCV infection without any other infectious agent, such as in liver-transplant patients with viral flare-ups 16 and following HIV infection. Only a few articles have mentioned the presence of epithelioid granulomas in the spectrum of chronic inflammation in patients with HCV. 17 Morphologically, granulomas are associated with central necrosis surrounded by a rim of lymphocytes, similar to that observed in cases of tuberculosis. This is our only experience of hepatic granulomas in a patient with HCV infection unrelated to HIV infection, drugs or drug abuse (Figure 1) . In this patient, in the open liver biopsy the hallmark histological changes of liver were the presence of epithelioid granulomas with central necrosis encircled by lymphocytes and fibrosis. No birefringent material or bile extravasations were detected. No acid-fast organism (AFO) was demonstrated. However, the morphological changes were suggestive of tuberculosis granulomas. Emile et al. 17 described five patients in whom no AFOs were demonstrated. Both tuberculosis and HCV infections are diseases of global distribution, with high prevalence and with the characteristics of epidemics and endemic diseases. The presence of HCV infection and epithelioid granulomas in liver without any AFO demonstrated by histological techniques requires further study with polymerase chain reaction (PCR) technique to eliminate the other possible causes.
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